Breaking News Instant updates and real-time market news.

QDEL

Quidel

$46.89

0.43 (0.93%)

, GNMK

GenMark

$5.03

0.35 (7.48%)

08:01
01/08/18
01/08
08:01
01/08/18
08:01

Week 52 flu data positive for Quidel, GenMark, says Canaccord

Canaccord analyst Mark Massaro said the CDC published its week 52 Influenza Surveillance Report and noted its increase and widespread flu incidence. He is encouraged by the data and now believes there is upside to revenue estimates for both Quidel (QDEL) and GenMark (GNMK). Massaro has a Buy ratings on both stocks, with a $52 price target on Quidel and a $10 price target on GenMark shares.

QDEL

Quidel

$46.89

0.43 (0.93%)

GNMK

GenMark

$5.03

0.35 (7.48%)

  • 08

    Jan

  • 26

    Feb

QDEL Quidel
$46.89

0.43 (0.93%)

12/14/17
PIPR
12/14/17
NO CHANGE
Target $50
PIPR
Overweight
Quidel may be in asset sale talks with Beckman, says Piper Jaffray
At 12 times EBITDA, shares of Quidel are a "good value," Piper Jaffray analyst William Quirk tells investors in a research note. The analyst believes Beckman's latest legal move has opened the door to a potential asset sale. Beckman filed a brief on Tuesday permitting Quidel additional time to reply to its initial legal filing, the analyst points out. He believes this may have been done because of the possibility that the two companies are in discussions around a BNP asset sale. Quirk thinks that if Quidel can get above $700M pre-tax from a sale of its BNP assets, it would essentially double its EBITDA for free. The analyst keeps an Overweight rating on Quidel with a $50 price target.
12/21/17
ADAM
12/21/17
NO CHANGE
Target $52
ADAM
Buy
Quidel price target raised to $52 from $48 at Canaccord
Canaccord analyst Mark Massaro raised his price target on Quidel (QDEL) to $52 from $48 following the company's conference call to discuss its recently acquired Triage and BNP assets from Alere (ALR). The analyst believes Quidel shares are undervalued as he believes management's estimates on synergies may prove conservative, particularly because savings are likely to continue after the end of 2018. Massaro reiterated his Buy rating on Quidel shares.
01/02/18
ADAM
01/02/18
NO CHANGE
Target $52
ADAM
Buy
Quidel remains undervalued at current levels, says Canaccord
Canaccord analyst Mark Massaro said he believes Quidel shares remain undervalued at current levels. He believes the company remains poised to benefit from a near-record start to the flu season, the synergies from its recent acquisitions and U.S. tax reform. Massaro reiterated his Buy rating and $52 price target on Quidel shares.
01/04/18
KING
01/04/18
UPGRADE
Target $52
KING
Buy
Quidel upgraded to Buy, named a Best Idea for 2018 at CL King
CL King upgraded Quidel to Buy from Neutral and named its a Best Idea for 2018 citing "compelling valuation" on post integration numbers. Analyst David Westenberg established a $52 price target on Quidel shares saying it trades at a "massive discount" to its diagnostic peers and said upside to the stock remains a strong flu season, a BNP buyout and market realization of value.
GNMK GenMark
$5.03

0.35 (7.48%)

09/18/17
09/18/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Teck Resources (TECK) initiated with a Sell at Axiom. 2. GenMark (GNMK) initiated with a Buy at BofA/Merrill. 3. Cirrus Logic (CRUS) initiated with an Underperform at BofA/Merrill. 4. Athenex (ATNX) initiated with an Outperform at Credit Suisse. 5. Brookfield Infrastructure (BIP) reinitiated with a Neutral at Credit Suisse. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/25/17
ADAM
09/25/17
NO CHANGE
ADAM
Genomic Health, Vermillion among 'few winners' after PAMA news, says Canaccord
After the CMS released the proposed 2018 draft Medicare reimbursement rates for clinical lab tests under the Protecting Access to Medicare Act, or PAMA, which marks a major overhaul of Medicare reimbursement for tests, Canaccord analyst Mark Massaro said the cuts were greater than he expected. He identifies the "losers" after the news as LabCorp (LH), Quest Diagnostics (DGX) and GenMark (GNMK) while he sees Genomic Health (GHDX), VeraCyte (VCYT) and Vermillion (VRML) as among the "few winners."
11/03/17
RAJA
11/03/17
DOWNGRADE
RAJA
Market Perform
GenMark downgraded to Market Perform from Outperform at Raymond James
Raymond James analyst Nicholas Jansen downgraded GenMark to Market Perform following the negative Q3 report and "sizable" reduction in Q4 guidance. The analyst said the combination of slower-than-anticipated European traction, a shift to more rentals, and delay in the US menu expansion are too much for his "patience to overcome."
11/03/17
ADAM
11/03/17
NO CHANGE
Target $10
ADAM
Buy
GenMark price target lowered to $10 from $14 at Canaccord
Canaccord analyst Mark Massaro lowered his price target on GenMark to $10 from $14 following mixed Q3 results. The analyst also has forecasts well below consensus for Q4, citing lower utilization of ePlex placements in Europe and more of a shift to reagent rentals vs. capital placements. Massaro maintained his Buy rating on GenMark shares as he said his long-term thesis remains intact.

TODAY'S FREE FLY STORIES

ANDX

Andeavor Logistics

$52.52

0.12 (0.23%)

16:31
01/19/18
01/19
16:31
01/19/18
16:31
Hot Stocks
Andeavor Logistics raises quarterly cash distribution to $1.00 per unit »

The fourth quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

16:30
01/19/18
01/19
16:30
01/19/18
16:30
Options
Preliminary option volume of 22.8M today »

Preliminary option volume…

TRNC

tronc

$19.53

0.3 (1.56%)

16:26
01/19/18
01/19
16:26
01/19/18
16:26
Periodicals
LA Times' CEO Ross Levinsohn to take leave of absence amid probe, DJ says »

Dow Jones added that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RKDA

Arcadia Biosciences

$0.27

0.0285 (11.88%)

16:25
01/19/18
01/19
16:25
01/19/18
16:25
Conference/Events
Arcadia Biosciences to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

FB

Facebook

$181.29

1.49 (0.83%)

16:23
01/19/18
01/19
16:23
01/19/18
16:23
Hot Stocks
Facebook provides update on trusted sources initiative »

Starting next week,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 31

    Jan

  • 07

    Feb

  • 28

    Feb

MS

Morgan Stanley

$57.46

1.62 (2.90%)

, APO

Apollo Global

$34.74

-0.33 (-0.94%)

16:21
01/19/18
01/19
16:21
01/19/18
16:21
Hot Stocks
Morgan Stanley reports 5% passive stake in Apollo Global »

In a regulatory filing,…

MS

Morgan Stanley

$57.46

1.62 (2.90%)

APO

Apollo Global

$34.74

-0.33 (-0.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 01

    Feb

HBNC

Horizon Bancorp

$28.49

0.37 (1.32%)

16:19
01/19/18
01/19
16:19
01/19/18
16:19
Syndicate
Breaking Syndicate news story on Horizon Bancorp »

Horizon Bancorp files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SANM

Sanmina

$35.45

0.5 (1.43%)

16:18
01/19/18
01/19
16:18
01/19/18
16:18
Hot Stocks
Breaking Hot Stocks news story on Sanmina »

Sanmina down 15% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SANM

Sanmina

$35.45

0.5 (1.43%)

16:17
01/19/18
01/19
16:17
01/19/18
16:17
Hot Stocks
Sanmina adopts consolidated restructuring plan »

On January 12, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBM

IBM

$162.37

-6.75 (-3.99%)

, AXP

American Express

$98.03

-1.83 (-1.83%)

16:17
01/19/18
01/19
16:17
01/19/18
16:17
General news
On The Fly: Top stock stories for Friday »

Stocks were mixed for…

IBM

IBM

$162.37

-6.75 (-3.99%)

AXP

American Express

$98.03

-1.83 (-1.83%)

GE

General Electric

$16.26

-0.51 (-3.04%)

FB

Facebook

$181.29

1.49 (0.83%)

NCNA

NuCana

$20.51

6.02 (41.55%)

ACOR

Acorda Therapeutics

$27.20

2.2 (8.80%)

BIIB

Biogen

$342.41

-2.03 (-0.59%)

IPHI

Inphi

$32.07

-3.33 (-9.41%)

MKC

McCormick

$99.19

-3.72 (-3.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 23

    Jan

  • 24

    Jan

  • 25

    Jan

  • 25

    Jan

  • 31

    Jan

  • 07

    Feb

  • 07

    Feb

  • 28

    Feb

  • 08

    Mar

$NSD

NASDAQ Market Internals

16:17
01/19/18
01/19
16:17
01/19/18
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

16:16
01/19/18
01/19
16:16
01/19/18
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENDP

Endo

$7.11

-0.24 (-3.27%)

, CVS

CVS Health

$79.85

0.5 (0.63%)

16:15
01/19/18
01/19
16:15
01/19/18
16:15
Periodicals
Delaware files lawsuit against opioid manufacturers, distributors, Reuters says »

Delaware has become the…

ENDP

Endo

$7.11

-0.24 (-3.27%)

CVS

CVS Health

$79.85

0.5 (0.63%)

WBA

Walgreens Boots Alliance

$76.47

0.47 (0.62%)

MCK

McKesson

$170.33

-1.45 (-0.84%)

CAH

Cardinal Health

$71.90

0.19 (0.26%)

ABC

AmerisourceBergen

$100.01

-0.85 (-0.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 06

    Feb

  • 08

    Feb

ITI

Iteris

$7.49

0.03 (0.40%)

16:12
01/19/18
01/19
16:12
01/19/18
16:12
Hot Stocks
Neil Subin sells $748K in Iteris shares »

Neil Subin, a beneficial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

SANM

Sanmina

$35.45

0.5 (1.43%)

16:11
01/19/18
01/19
16:11
01/19/18
16:11
Earnings
Sanmina sees Q2 adjusted EPS 40c-50c, consensus 70c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SANM

Sanmina

$35.45

0.5 (1.43%)

16:09
01/19/18
01/19
16:09
01/19/18
16:09
Earnings
Sanmina reports Q1 preliminary adjusted EPS 48c, consensus 71c »

Reports Q1 preliminary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$332.26

-0.74 (-0.22%)

16:07
01/19/18
01/19
16:07
01/19/18
16:07
Periodicals
Breaking Periodicals news story on Lockheed Martin »

U.S. approves sale of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 07

    Mar

CPLA

Capella Education

$80.50

0.7 (0.88%)

, STRA

Strayer

$93.08

0.9 (0.98%)

16:06
01/19/18
01/19
16:06
01/19/18
16:06
Hot Stocks
Capella Education shareholders approve proposed merger with Strayer »

Capella Education (CPLA)…

CPLA

Capella Education

$80.50

0.7 (0.88%)

STRA

Strayer

$93.08

0.9 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 19

    Jan

ADM

Archer Daniels

$40.61

0.13 (0.32%)

, BG

Bunge

$69.78

0.14 (0.20%)

16:03
01/19/18
01/19
16:03
01/19/18
16:03
Periodicals
Archer Daniels made takeover approach to Bunge, WSJ says »

Archer Daniels Midland…

ADM

Archer Daniels

$40.61

0.13 (0.32%)

BG

Bunge

$69.78

0.14 (0.20%)

GLNCY

Glencore

$11.29

-0.02 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 14

    Feb

C

Citi

$78.16

0.77 (0.99%)

16:01
01/19/18
01/19
16:01
01/19/18
16:01
Conference/Events
Citigroup to hold a conference call »

CFO Gerspach and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 24

    Jan

GOLF

Acushnet Holdings

$21.50

0.65 (3.12%)

16:01
01/19/18
01/19
16:01
01/19/18
16:01
Hot Stocks
Acushnet Holdings acquires Linkgs & Kings, terms not disclosed »

Acushnet Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BG

Bunge

$69.79

0.145 (0.21%)

, ADM

Archer Daniels

$40.66

0.18 (0.44%)

15:58
01/19/18
01/19
15:58
01/19/18
15:58
Hot Stocks
Breaking Hot Stocks news story on Bunge, Archer Daniels »

Bunge jumps 10% after…

BG

Bunge

$69.79

0.145 (0.21%)

ADM

Archer Daniels

$40.66

0.18 (0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 14

    Feb

BG

Bunge

$69.76

0.12 (0.17%)

, ADM

Archer Daniels

$40.66

0.18 (0.44%)

15:57
01/19/18
01/19
15:57
01/19/18
15:57
Periodicals
Breaking Periodicals news story on Bunge, Archer Daniels »

Archer Daniels made…

BG

Bunge

$69.76

0.12 (0.17%)

ADM

Archer Daniels

$40.66

0.18 (0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 14

    Feb

HGT

Hugoton Royalty Trust

15:57
01/19/18
01/19
15:57
01/19/18
15:57
Hot Stocks
Breaking Hot Stocks news story on Hugoton Royalty Trust »

Hugoton Royalty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCSA

Comcast

$41.85

0.17 (0.41%)

15:50
01/19/18
01/19
15:50
01/19/18
15:50
Options
Bullish option play in Comcast ahead of earnings next week »

Bullish option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.